News
Deferoxamine does not improve 90-day outcomes after ICH
HONOLULU – The drug is safe, and data suggest that it could improve 180-day outcomes.
News
Vaccination and antiviral treatment do not affect stroke risk following shingles
HONOLULU – Preventing shingles through vaccination might be the best method for preventing shingles-associated acute...
News
Cilostazol plus aspirin or clopidogrel reduces the risk of recurrent stroke
HONOLULU – Dual therapy with cilostazol and aspirin or clopidogrel did not increase the risk of serious bleeding.
News
Researchers compare focused ultrasound and DBS for essential tremor
LAS VEGAS – Focused ultrasound and DBS have similar efficacy in essential tremor, but their safety profiles and...
News
DBS may improve nonmotor symptoms in Parkinson’s disease
LAS VEGAS – Stimulation of the GPI, but not of the STN, is associated with improvement in sialorrhea and urinary...
News
Peripheral nerve stimulation reduces hand tremor
LAS VEGAS – Hand tremor and activities of daily living are improved by noninvasive neuromodulation in patients with...
News
Benefit of thrombectomy may be universal
The proportional benefit of thrombectomy is uniform among various subgroups of patients with acute ischemic stroke.
News
DBS provides long-term benefits for patients with Parkinson’s disease
LAS VEGAS – A large-scale collection of outcomes suggests that DBS offers sustained improvement of motor and nonmotor symptoms.
News
Frailty may affect the expression of dementia
People with higher degrees of frailty may be more likely to have more Alzheimer’s disease pathology and clinical dementia.
News
Population-level rate of SUDEP may have decreased
NEW ORLEANS – It is unclear whether the observed decline in SUDEP incidence resulted from an intensified focus on risk reduction.
News
Onset of pediatric status epilepticus may have a circadian pattern
NEW ORLEANS - Onset of refractory pediatric status epilepticus may peak between 10 a.m. and 11 a.m.
News
Alcohol use, psychological distress associated with possible RBD
These associations were previously unreported, and the results suggest the need for further study.
News
Daclizumab beta may be superior to interferon beta on MS disability progression
A post hoc analysis indicates that daclizumab beta has superior efficacy, compared with interferon beta-1a, regardless of patients’ baseline...
News
AAN publishes position statement on brain death
The association calls for uniform laws and policies regarding brain death, as well as continued research and public education.